Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Alder Biopharmaceuticals Company Profile (NASDAQ:ALDR)

Consensus Ratings for Alder Biopharmaceuticals (NASDAQ:ALDR) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $24.67 (80.31% upside)

Analysts' Ratings History for Alder Biopharmaceuticals (NASDAQ:ALDR)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/2/2014Leerink SwannLower Price Target$26.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
6/11/2014BernsteinInitiated CoverageOutperform$30.00ViewTweet This Rating  Share This Rating on StockTwits
6/11/2014Sanford C. BernsteinInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
6/2/2014Credit SuisseInitiated CoverageOutperform$20.00ViewTweet This Rating  Share This Rating on StockTwits
6/2/2014Wells Fargo & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
6/2/2014Leerink SwannInitiated CoverageOutperform$26.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/21/2012 forward)
Discuss Alder Biopharmaceuticals